Top Chinese drugmaker Hengrui soars in Hong Kong trading debut
Hengrui’s debut, which comes on the heels of CATL’s blockbuster Hong Kong premiere, builds on Hong Kong’s hot…
Generic Drugmaker Amneal Clocks Mixed Q4 Earnings, Plans Expansion In High-Growth Areas Like Weight Loss Products, Biosimilars – Amneal Pharmaceuticals (NASDAQ:AMRX)
On Friday, Amneal Pharmaceuticals Inc. AMRX reported fourth-quarter adjusted EPS of 12 cents, down from 14 cents a year ago…
Huge distressed drugmaker seeks sale in Chapter 11 bankruptcy
The biotechnology sector has faced a spike in bankruptcy filings over the last two years which has begun…
Ken Griffin’s Citadel bets £300mn against drugmaker GSK
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this…